Transdermal nicotine use in postmenopausal women: Does the treatment efficacy differ in women using and not using hormone replacement therapy?

Nicotine and Tobacco Research

Volumn 6, Issue 5, 2004, Pages 777-788

  Allen, Sharon S ^a   Hatsukami, Dorothy K ^a   Bade, Tracy ^a   Center, Bruce ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYRIN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; NICOTINE; PLACEBO; SEX HORMONE;

ADULT; AGE; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; MULTIVARIATE ANALYSIS OF COVARIANCE; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PATIENT MONITORING; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SCORING SYSTEM; SKIN IRRITATION; SMOKING CESSATION; TRANSDERMAL PATCH; VAGINA BLEEDING; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; COUNSELING; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; GANGLIONIC STIMULANTS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; MOTOR SKILLS DISORDERS; NICOTINE; PLACEBOS; POSTMENOPAUSE; REACTION TIME; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 8644267515     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220042000274239     Document Type: Article

References (81)

1. Allen, S. S., Hatsukami, D. K., & Christianson, D. (2003). Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: A comparison of postmenopausal women using and not using hormone replacement therapy. Nicotine and Tobacco Research, 5, 49-59.
2. Allen, S. S., Hatsukami, D., Christianson, D., & Brown, S. (2000). Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine and Tobacco Research, 2, 231-241.
3. Allen, S. S., Hatsukami, D. K., Christianson, D., & Nelson, D. (1996). Symptomatology and energy intake during the menstrual cycle in smoking women. Journal of Substance Abuse, 8, 303-319.
4. Allen, S. S., Hatsukami, D. K., Christianson, D., & Nelson, D. (1999). Withdrawal and pre-menstrual symptomatology during the menstrual cycle in short-term smoking abstinence: Effects of menstrual cycle on smoking abstinence. Nicotine and Tobacco Research, 1, 129-142.
5. American Psychiatric Assocciation. (1994). Diagnostic and statistical manual of mental disorders, 4th edition. Washington, D.C.: Author.
6. Aylward, M. (1973). Plasma tryptophan levels and mental depression in postmenopausal subjects: Effects. IRCS Journal of Medical Science, 1, 30-34.
7. Balfour, J. A., & Heel, R. C. (1990). Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Drugs, 40, 561-82.
8. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 53-63.
9. Bjorn, I., Bixo, M., Nojd, K. S., Collberg, P., Nyberg, S., Sundstrom-Poromaa, I., & Backstrom, T. (2002). The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecology and Endocrinology, 16, 1-8.
10. Carlson, M. C., Zandi, P. P., Plassman, B. L., Tschanz, J. T., Welsh-Bohmer, K. A., Steffens, D. C., Bastian, L. A., Mehta, K. M., & Breitner, J. C. Cache County Study Group. (2001). Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study. Neurology, 57, 2210-2216.
11. Centers for Disease Control and Prevention. (1993). Smoking cessation during previous year among adults - United States, 1990 and 1991. Morbidity and Mortality Weekly Report, 42, 504-507.
12. Centers for Disease Control and Prevention. (1999). Cigarette smoking among adults - United States, 1997. Morbidity and Mortality Weekly Report, 48, 994-996.
13. Centers for Disease Control and Prevention. (2000). Cigarette smoking among adults - United States, 1998. Morbidity and Mortality Weekly Report, 49, 881-884.
14. Centers for Disease Control and Prevention. (2002). Cigarette smoking among adults - United States, 2000. Morbidity and Mortality Weekly Report, 51, 642-645.
15. Collins, A., & Landgren, B. M. (1995). Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: A population based study. Maturitas, 20, 101-111.
16. DeBon, M., Klesges, R. C., & Klesges, L. M. (1995). Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addictive Behaviors, 20, 335-343.
17. Dennerstein, L., Brown, J. B., Gotts, G., Morse, C. A., Farley, T. M., & Pinol, A. (1993). Menstrual cycle hormonal profiles of women with and without premenstrual syndrome. Journal of Psychosomatics Obstetrics Gynecology, 14, 259-268.
18. Ditkoff, E. C., Crary, W. G., Cristo, M., & Lobo, R. A. (1991). Estrogen improves psychological function in asymptomatic postmenopausal women. Obstetrics and Gynecology, 78, 991-995.
19. Duff, S. J., & Hampson, E. (2000). A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy. Hormones and Behavior, 38, 262-276.
20. Fagerström, K. O. (1978). Measuring degree of physical dependence to tobacco smoking with references to individualization of treatment. Addictive Behaviors, 3, 235-241.
21. Fagerström, K. O. (1989). Treatment of nicotine dependence. Progress in Brain Research, 79, 321-326.
22. Fiore, M. C. (2000). US public health service clinical practice guideline: Treating tobacco use and dependence. Respiratory Care, 45, 1200-1262.
23. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. R., Heyman, R. B., Holbrook, J., Jaen, C. R., Kottke, T. E., Lando, H. A., Mecklenburg, R., Mullen, P. D., Nett, L. M., Robinson, K., Stitzer, M. L., Tommasello, A. C., Villejo, L., & Wewers, M. E. (1996). Smoking Cessation. Clinical Practice Guideline No 18. Rockville, MD: U.S. Department of Health and Human Services, Agency for Health Care Policy and Research, AHCPR Publication No. 96-0692.
24. Fiore, M. C., Hatsukami, D. K., & Baker, T. B. (2002). Effective tobacco dependence treatment. Journal of the American Medical Association, 288, 1768-1771.
25. Fiore, M. C., Pierce, J. P., Remington, P. L., & Fiore, B. J. (1990). Cigarette smoking: The clinician's role in cessation, prevention, and public health. Disease-a-Month, 35, 186-249.
26. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation: A meta analysis. Journal of the American Medical Association, 271, 1940-1947.
27. Fortmann, S. P., & Killen, J. D. (1994). Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. American Journal of Epidemiology. 140, 39-51.
28. Giovino, G. A., Schooley, M. W., Zhu, B. P., Chrismon, J. H., Tomar, S. L., Pedicord, J. P., Merritt, R. K., Husten, C. G., & Ericksen, M. P. (1994). Surveillance for selected tobacco-use behaviors - United States, 1900-1994. Morbidity and Mortality Weekly Report, CDC Surveillance Summaries, 43, 1-43.
29. Gordon, S. F. (1995). Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. American Journal of Obstetrics and Gynecology, 173, 998-1004.
30. Great American Smokeout. (1999). Great American Smokeout - November 18, 1999. Tobacco use in the United States, 1900-1999. Cigarette smoking among adults - United States, 1997. Morbidity and Mortality Weekly Report, 48, 985-996.
31. Hamilton, J. A., & Yonkers, K. A. (1996). Sex differences in pharmacokinetics of psychotropic medications, part I: Physiological basis for effects. In M. F. Jensvold et al. (Eds.), Psychopharmacology and Women: Sex, Gender, and Hormones. Washington DC: American Psychiatric Press, pp. 11-42.
32. Hatsukami, D. K., Skoog, K., Allen, S. S., & Bliss, R. (1995). Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms. Experimental and Clinical Psychopharmacology, 3, 163-173.
33. Heishman, S. J., Taylor, R. C., & Henningfield, J. E. (1994). Nicotine and smoking: A review of effects on human performance. Experimental and Clinical Psychopharmacology, 2, 345-395.
34. Hindmarch, I. (1980). Psychomotor function and psychoactive drugs. British Journal of Clinical Psychopharmacology, 10, 189-209.
35. Hughes, J. R., & Glaser, M. (1993). Transdermal nicotine for smoking cessation. Health Values, 17, 25-31.
36. Hughes, J. R., Gust, S. W., Skoog, K., Keenan, R. M., & Fenwick, J. W. (1991). Symptoms of tobacco withdrawal. Archives of General Psychiatry, 48, 52-59.
37. Hughes, J. R., & Hatsukami, D. K. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
38. Hughes, J. R., & Hatsukami, D. K. (1998). Errors in using tobacco withdrawal scale. Tobacco Control, 7, 92-93.
39. Hughes, J. R., Hatsukami, D. K., Pickens, R. W., Krahn, D., Malin, S., & Luknic, A. (1984). Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology, 83, 82-87.
40. Hughes, J. R., Hatsukami, D. K., & Skoog, K. P. (1986). Physical dependence on nicotine in gum. A placebo substitution trial. Journal of the American Medical Association, 255, 3277-3279.
41. Hughes, J. R., Higgins, S. T., & Hatsukami, D. K. (1989). Effects of abstinence from tobacco. In L. T. Kozlowski, H. Annis, H. D., et al. (Eds.), Research Advances in Alcohol and Drug Problems. New York: Plenum Press.
42. Jacobs, D. M., Tang, M. X., Stern, Y., Sano, M., Marder, K., Bell, K. L., Schofield, P., Dooneief, G., Gurland, B., & Mayeux, R. (1998). Cognitive function in nondemented older women who took estrogen after menopause. Neurology, 50, 368-373.
43. Jorenby, D. E., Hatsukami, D. K., Smith, S. S., Fiore, M. C., Allen, S., Jensen, J., & Baker, T. B. (1996). Characterization of tobacco withdrawal symptoms: Transdermal nicotine reduces hunger and weight gain. Psychopharmacology, 128, 130-138.
44. Killen, J. D., Fortmann, S. P., Newman, B., & Varady, A. (1990). Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. Journal of Consulting and Clinical Psychology, 58, 85-92.
45. Klaiber, E. L., Broverman, D. M., Vogel, W., & Kobayashi, T. (1979). Estrogen therapy for severe persistent depressions in women. Archives of General Psychiatry, 36, 550-554.
46. Kronenberg, F. (1991). Hot flashes. In R.A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects (pp.157-178). Philadelphia: Lippincott Williams and Wilkins.
47. Lorr, M., & McNair, D. M. (1982). Profile of Mood States: Bipolar Form (POMS-BI). San Diego, Educational Industrial Testing Service.
48. Lynch, W. J., Roth, M. E., & Carroll, M. E. (2001). Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats. Pharmacology, Biochemistry and Behavior, 68, 641-646.
49. Marks, J. L., Hair, C. S., Klock, S. C., Ginsburg, B. E., & Pomerleau, C. S. (1994). Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder. Journal of Substance Abuse, 6, 235-243.
50. McEwen, B. S. (1980). The brain as a target organ of endocrine hormones. In D. T. Kreiger and J. S. Hughes (Eds), Neuroendocrinology. Sunderland: Sinauer Associates.
51. National Center for Health Statistics. (1997). Fertility, family planning, and women's health: New data from the 1995 National Survey of Family Growth. Vital and Health Statistics. Series 23, No. 19. Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Standards.
52. O'Hara, P., Portser, S. A., & Anderson, B. P. (1989). The influences of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addictive Behaviors, 14, 595-600.
53. Palinkas, L. A., & Barrett-Conner, E. (1992). Estrogen use and depressive symptoms in postmenopausal women. Obstetrics and Gynecology, 80, 30-36.
54. PEPI Trial Writing Group. (1995). Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Journal of American Medical Association, 273, 199-208.
55. Perkins, K. A. (1999). Nicotine discrimination in men and women. Pharmacology, Biochemistry and Behavior, 64, 295-299.
56. Perkins, K. A. (2001). Smoking cessation in women. Special considerations. CNS Drugs, 15, 391-411.
57. Perkins, K. A., Epstein, L. H., & Pastor, S. (1990). Changes in energy balance following smoking cessation and resumption of smoking in women. Journal of Consulting and Clinical Psychology, 58, 1-5.
58. Perkins, K. A., Levine, M., Marcus, M., & Shiffman, S. (2000). Tobacco withdrawal in women and menstrual cycle phase. Journal of Consulting and Clinical Psychology, 68, 176-180.
59. Pomerleau, C. S., Garcia, A. Q., Pomerleau, O. F., & Cameron, O. G. (1992). The effects of menstrual phase and nicotine cessation on nicotine intake and on biochemical and subjective measures in women smokers: A preliminary report. Psychoneuroendocrinology, 17, 627-639.
60. Pomerleau, C. S., Tate, J. C., Lumley, M. A., & Pomerleau, O. F. (1994). Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms. Journal of Substance Abuse., 6, 433-440.
61. Rimer, B. K., Orleans, C. T., Keintz, M. K., Cristinzio, S., & Fleisher, L. (1990), The older smoker: Status, challenges and opportunities for intervention. Chest, 97, 225-229.
62. Roth, M. E., Casimir, A. G., & Carroll, M. E. (2002). Influence of estrogen in the acquisition of intravenously self-administered heroin in female rats. Pharmacology, Biochemistry, and Behavior, 72, 313-318.
63. Rubinow, D. R., Roca, C. A., & Schmidt, P. J. (1999). Estrogen and depression in women. In R. A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects. (pp. 189-194). Philadelphia: Lippincott Williams and Wilkins.
64. Sachs, D. P., & Leischow, S. J. (1991). Pharmacological approaches to smoking cessation. Clinics in Chest Medicine, 12, 769-791.
65. Shaywitz, S. E., Shaywitz, B. A., Pugh, K. R., Fulbright, R. K., Skudlarski, P., Mencl, W. E., Constable, R. T., Naftolin, F., Palter, S. F., Marchionem, K. E., Katz, L., Shankweiler, D. P., Fletcher, J. M., Lacadie, C., Keltz, M., & Gore, J. C. (1999). Effects of estrogen on brain activation patterns in postmenopausal women during working memory tasks. Journal of the American Medical Association, 281, 1197-1202.
66. Sherwin, B. B. (1991). The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 72, 336-343.
67. Sherwin, B. B. (1999). Impact of the changing hormonal milieu on psychological functioning. In: R.A. Lobo (Ed.) Treatment of the postmenopausal woman: Basic and clinical aspects, (pp. 179-188). Philadelphia: Lippincott Williams and Wilkins.
68. Sherwin, B. B., & Suranyi-Cadotte, B. E. (1990). Up regulatory effects of estrogen on platelet 3H imipramine binding sites in surgically menopausal women. Biological Psychiatry, 28, 339-348.
69. Shumaker, S. A., Legault, C., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones, B. N. III, Assaf, A. R., Jackson, R. D., Kotchen, J. M., Wassertheil-Smoller, S., & Wactawski-Wende, J. WHIMS Investigators. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in post-menopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association, 2651-2562.
70. Silagy, C., Mant, D., Fowler, G., & Lodge, M. (1994). Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet, 343, 139-142.
71. Steinberg, J. L., & Cherek, D. R. (1989). Menstrual cycle and cigarette smoking. Addictive Behaviors, 14, 173-179.
72. Thorndike, A. N., Biener, L., & Rigotti, N. A. (2002). Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. American Journal of Public Health, 92, 437-442.
73. Thorne, D. R., Genser, S. G., Sing, H. C., & Hegge, F. W. (1985). The Walter Reed Performance Assessment Battery. Neurobehavioral Toxicology and Teratology, 7, 415-418.
74. Tiffany, S. T., & Drobes, D. J. (1991). The development and initial validation of a questionnaire on smoking urges. British Journal of Addiction, 86, 1467-1476.
75. U.S. Census Bureau. (2000). Census.2000 Summary File 1, Matrices P13 and PCT12, Retrieved September 5, 2003, from http://factfinder.census.gov/servlet/ QTTable?dsme=D&geo_id=D&qr_name=DEC_2000_SF1_U_QTP1&_lang=en
76. U.S. Department of Health and Human Services. (1988). The health consequences of smoking: Nicotine addiction. A report of the Surgeon General. Department of Health and Human Services, Publication No. (CDC) 88-8406. Washington DC: Government Printing Office.
77. U.S. Department of Health and Human Services. (1990). Health benefits of smoking cessation: A report of the Surgeon General (DHHS Publication No. (CDC) 90-8416). Washington, DC: U.S. Department of Health and Human Services.
78. West, R. J., & Jarvis, M. J. (1986). Effects of nicotine on finger tapping rate in nonsmokers. Pharmacology, Biochemistry and Behavior, 25, 727-731.
79. Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Journal of the American Medical Association, 288, 321-333.
80. Yankelovich Partners Smoking Cessation Study. Report prepared for Ketchum Public Relations and their client American Lung Association. Norwalk (CT): Yankelovich Partners, July 27, 1998. Accessed August 15, 2000, from http://www.lungusa.org/partner/yank/1.html
81. Zweifel, J. E., & O'Brien, W. H. (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology, 22, 189-212.